Search
Kazia Therapeutics Ltd
KZIAAdd to Watchlist
9.610USD
+0.010+0.10%
Market hours 09/24, 15:47（ET）
149.42MMarket Cap
LossP/E TTM
Kazia Therapeutics Ltd (KZIA) Stock Price Target & Forecast
Analyst Rating
Based on 6 analysts giving stock ratings to Kazia Therapeutics Ltd in the past month.
Buy
1 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
26.500USD+142.67%
KZIA Analyst Recommendation Trends
In the current month, KZIA has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KZIA average Analyst price target in the last month is 26.500.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
0
0
0
0
0
0
5
5
4
3
3
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
4
3
3
2
2
2
Financial Forecasting
Based on analysts' estimates, KZIA EPS is projected to reach -0.925 in FY2025H2, following reported EPS of -40.600 in FY2025H1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2024H2
FY2025
FY2025H1
FY2023H2
FY2025H2
FY2026H1
Forecast
--
--
-12.16
-3.86
-0.92
-0.23
Actual
-0.67
-12.22
-40.60
--
--
--
Surprise
--
--
-233.84%
--
--
--
FAQs
What is Kazia Therapeutics Ltd's expected revenue for the next quarter?
Kazia Therapeutics Ltd's expected revenue is 563.27K.
What is Kazia Therapeutics Ltd's price target?
Analysts forecast that Kazia Therapeutics Ltd's price target is USD 16.50, with the highest forecast at USD 20.00 and the lowest forecast at USD 13.00.
How have Kazia Therapeutics LtdKZIA's recent earnings per share performed?
The market expectation was USD -40.60, while Kazia Therapeutics LtdKZIA's earnings per share (EPS) for the previous quarter was USD -12.22. EPS for the next quarter is expected at USD -0.23.
What is the analyst rating for Kazia Therapeutics Ltd?
Based on the ratings of Kazia Therapeutics Ltd's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.